Bio-Techne's Ella platform gains CE-IVD marking

{
  "signal_id": "b07dd0cc-d2cc-449c-a959-fbef095a2840",
  "signal_type": "news",
  "signal_subtype": "launches",
  "detected_at": "2026-02-17T11:28:00+00:00",
  "company": {
    "name": "Bio-Techne",
    "domain": "bio-techne.com"
  },
  "data": {
    "url": "https://www.pathologyinpractice.com/story/50667/bio-technes-ella-platform-gains-ce-ivd-marking",
    "title": "Bio-Techne's Ella platform gains CE-IVD marking",
    "excerpt": "Bio-Techne's Ella platform gains CE-IVD marking.\n\n* February 17, 2026\n\nBio-Techne has announced that the Ella benchtop immunoassay platform has received CE-IVD marking and is now available for sale in the European Union.\n\nElla is a compact, cartridge-based immunoassay system that delivers accurate biomarker results in under 90 minutes with minimal hands-on time. By simplifying the manual steps of traditional immunoassays, Ella reduces operator variability and provides high-quality, reproducible data suitable for both translational research and clinical applications.\n\nThe platform is compatible with Simple Plex assays, which remain for research use only, and are powered by R&D Systems antibodies and proteins. With more than 390 analytes across neuroscience, immunology, oncology, and cell and gene therapy, the Simple Plex portfolio enables researchers to maintain consistency and data quality while working efficiently across a wide range of applications.\n\n\"Ella's CE-IVD certification marks a significant step forward in advancing precision diagnostics,\" said Will Geist, President of Bio-Techne's Protein Sciences Segment. \"It reflects our commitment to providing innovative tools that enhance clinical decision-making and improve patient outcomes.\"\n\nWith CE-IVD marking now in place, hospitals, clinical laboratories, or other European organisations may use Ella as a validated platform...",
    "product": "Ella benchtop immunoassay platform",
    "summary": "Bio-Techne launched Ella benchtop immunoassay platform on Feb 17th '26.",
    "category": "launches",
    "found_at": "2026-02-17T11:28:00Z",
    "planning": false,
    "image_url": "https://www.pathologyinpractice.com/api/file/70611",
    "confidence": 0.349,
    "product_data": {
      "full_text": "Ella benchtop immunoassay platform",
      "fuzzy_match": true
    },
    "product_tags": [
      "online_technology",
      "general_technology"
    ],
    "published_at": "2026-02-17T11:28:00Z",
    "effective_date": "2026-02-17",
    "job_title_tags": [
      "general_technology"
    ],
    "article_sentence": "Bio-Techne has announced that the Ella benchtop immunoassay platform has received CE-IVD marking and is now available for sale in the European Union."
  }
}

curl https://signals.autobound.ai/v1/signals/b07dd0cc-d2cc-449c-a959-fbef095a2840 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"bio-techne.com","limit":20}'